1.0CZECRIN - Česká národní síť pro podporu klinického výzkumuhttps://czecrin.cz/en/Markéta Salačováhttps://czecrin.cz/en/author/marketa/rich600338<blockquote class="wp-embedded-content" data-secret="AMbZkHBXVJ"><a href="https://czecrin.cz/en/project/kh-seotp/">KH SEOTP</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://czecrin.cz/en/project/kh-seotp/embed/#?secret=AMbZkHBXVJ" width="600" height="338" title="“KH SEOTP” — CZECRIN - Česká národní síť pro podporu klinického výzkumu" data-secret="AMbZkHBXVJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://czecrin.cz/wp-includes/js/wp-embed.min.js /* ]]> */ </script> SEOTP – Safety and efficacy of olanzapine therapy in psychosis: influence of genetic and epigenetic factors – covariates of treatment response SEOTP is a phase IV clinical trial to improve and innovate existing treatment approaches for psychosis based on genotype and endophenotype, including pharmacokinetic analysis, to minimise the adverse effects of olanzapine treatment and to […]https://czecrin.cz/wp-content/uploads/2021/01/SEOTP-2-1024x415.png